WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ: 330350)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,820.00
+20.00 (0.29%)
Dec 27, 2024, 9:00 AM KST

WITHUS PHARMACEUTICAL Co.,LTD. Revenue

WITHUS PHARMACEUTICAL Co.,LTD. had revenue of 27.64B KRW in the quarter ending September 30, 2024, with 37.01% growth. This brings the company's revenue in the last twelve months to 105.74B, up 53.30% year-over-year. In the year 2023, WITHUS PHARMACEUTICAL Co.,LTD. had annual revenue of 80.12B with 23.87% growth.

Revenue (ttm)
105.74B
Revenue Growth
+53.30%
P/S Ratio
0.87
Revenue / Employee
873.87M
Employees
121
Market Cap
92.55B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202380.12B15.44B23.87%
Dec 31, 202264.68B7.26B12.65%
Dec 31, 202157.42B4.01B7.51%
Dec 31, 202053.41B1.01B1.93%
Jun 30, 202052.39B661.12M1.28%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 292.86T
SK hynix 57.73T
LG Energy Solution 27.17T
Samsung Biologics Co.,Ltd. 4,364.39B
Hyundai Motor Company 170.28T
Kia Corporation 104.63T
Celltrion 2,876.25B
KB Financial Group 14.11T
Revenue Rankings